Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Clinical trial NCT05526924 · RECRUITING

Trial details

NCT number: NCT05526924
Sponsor: University of Chicago
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Head and Neck Carcinoma Head and Neck Cancer Stage IV Head and Neck Cancers - Throat

Start date: 2023-03-07
Primary completion: 2028-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.